1.Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2000;30:1144-50.
2. Johnston SL, Unsworth J, Gompels MM. Adrenaline given outside the context of life threatening allergic reactions. BMJ 2003;326:589-90.
3. McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 2003;327:1332-5.
4. Simons FE, Ardusso LR, Bilo MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. The World Allergy Organization journal 2011;4:13-37.
5. Gallagher M, Worth A, Cunningham-Burley S, Sheikh A. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2011;41:869-77.
6. Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). The Journal of allergy and clinical immunology 2000;106:171-6.
7. Chipps BE. Update in Pediatric Anaphylaxis: A Systematic Review. Clinical pediatrics 2013.
8. Campbell RL, Manivannan V, Hartz MF, Sadosty AT. Epinephrine auto-injector pandemic. Pediatric emergency care 2012;28:938-42.
9. Haute Autorité de Santé H. Epipen (adrénaline auto-injectable). In.
Mise au point
Les urgences psychiatriques en médecine générale
Étude et pratique
Mortalité liée au tabac, le sevrage bénéfique quel que soit l’âge
Cas clinique
Le kyste osseux anévrismal
Recommandation
Le RGO du nourrisson